Abstract

BACKGROUNDDrug hypersensitivity reactions (DHR) can significantly impair patients’ health-related quality of life (HRQoL). However, tools for HRQoL assessment for patients with DHR are time-consuming and remain underutilized. OBJECTIVETo develop and validate an optimized version of the Drug Hypersensitivity Quality of Life Questionnaire (DrHy-Q) designed for everyday clinical use. METHODSItem response theory (IRT), a statistical framework for psychometric measurement, was used to evaluate the 15 questions from the original DrHy-Q for their respective item difficulty, discrimination, and information using prospective data from 243 patients with histories of suspected/confirmed DHR before allergy workup. Accordingly, the best-performing items were identified to develop a 6-item optimized version (DrHy-Q6), which was subsequently validated with another prospective cohort of 156 patients. RESULTSAll 15 items of the original DrHy-Q demonstrated satisfactory parameters in IRT analysis, including very high discrimination (>1.7), appropriate difficulty (in between -1.5 and 1.5) and good information (a high and broad peak in the information curve). Six items with top-ranked IRT parameters were identified to construct an optimized version, which we named the DrHy-Q6. The DrHy-Q6 demonstrated a 1-factor structure with an improved fit compared to the original DrHy-Q (comparative fit index = 0.985, Tucker–Lewis’s index = 0.974), excellent convergent validity (Unadjusted Pearson correlation with the full version = 0.955; adjusted = 0.894, p<0.001), reliability (Cronbach’s α and McDonald’s ω = 0.93), divergent validity (Pearson correlation with all Short Form 12-item Healthy Survey Version 2 [SF-12v2] subscales < 0.60, p<0.001) and discriminant validity (significantly higher scores with multiple DHR labels [42.45 ± 27.26 vs. 32.93 ± 26.66], p=0.013). CONCLUSIONSFrom an IRT perspective, the DrHy-Q and all its constituent items are psychometrically valid for HRQoL assessment. We propose an optimized 6-item version (DrHy-Q6) as an abbreviated alternative for assessing HRQoL in patients with DHR, especially for routine use in clinical practice. Patients and physicians may benefit from its streamlined length and simpler scoring algorithm.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call